Creative Biogene provides customized molecular biology reagents and professional technical services to customers in the life science research field
Learn more>>
Stable cell lines with specific gene over-expression or knock-down are very helpful in gene function analysis, target discovery, target vali...
Adenoviruses have a very broad host range, and can infect human and other mammalian cell lines or primary cells, including replicative as we...
Kit is a collection of reagents or devices that can perform a specific biological experiment. The components of the kit can be preserved for...
Creative Biogene is the leading global client service and solutions provider for scientific research
Learn more>>
CRISPR/Cas9 PlatformCB owned by Creative Biogene performs gene knockout/knockin program with CRISPR/Cas9 system, from designing gRNA constructs to transfection and single clone generation of a wide range of cells, including difficult-to-transfect and tumor cell lines, as well as plants, mouse and other animal models.
Learn more
From many years of groundbreaking work with virus vector design to the latest gene therapy technologies support, our QVirusTM Platform offers a comprehensive portfolio of services for the efficient design, development, manufacturing and analytical testing of virus vector products.
Learn more
Complete solutions are provided for RNA discovery, expression analysis, functional research and mechanism analysis. Our next-generation sequencing and microarray platforms enable researchers to explore the world of RNA on an unprecedented scale, and map all RNAs involved in cell life programs, human diseases, and drug discovery.
Learn more
We are fully engaged in developing unique technologies to facilitate the investigation of microbial research. Our high-quality products and services include microbial genome editing, identification, sequencing, proteomics, and metabolomics. We possess a mature fermentation platform consisting of large fermentation tanks, bioreactors, and large-scale purification systems.
Learn more
